Table of Contents_x000D_
List of Tables_x000D_
List of Figures_x000D_
1 Introduction_x000D_
1.1 What Is This Report About?_x000D_
1.2 Dental Implants & Abutments Market Segmentation_x000D_
1.3 Definitions of Markets Covered in the Report_x000D_
2 Dental Implants & Abutments Market, United States_x000D_
2.1 Dental Implants & Abutments Market, United States, Revenue ($m), 2024-2036_x000D_
2.1.1 Dental Abutments Market, United States, Revenue ($m), by Segment, 2024-2036_x000D_
2.1.2 Dental Implants Market, United States, Revenue ($m), by Segment, 2024-2036_x000D_
2.2 Dental Implants & Abutments Market, United States, Volume (Units), 2024-2036_x000D_
2.2.1 Dental Abutments Market, United States, Volume (Units), by Segment, 2024-2036_x000D_
2.2.2 Dental Implants Market, United States, Volume (Units), by Segment, 2024-2036_x000D_
2.3 Dental Implants & Abutments Market, United States, Average Price ($), 2024-2036_x000D_
2.4 Dental Implants & Abutments Market, United States, Company Share by Revenue ($m), 2025_x000D_
3 Dental Implants & Abutments Market Pipeline Products_x000D_
3.1 Dental Implants & Abutments Market Pipeline Products_x000D_
3.2 Dental Implants & Abutments – Pipeline Products by Stage of Development_x000D_
3.3 Dental Implants & Abutments – Pipeline Products by Segment_x000D_
3.4 Dental Implants & Abutments – Pipeline Products by Territory_x000D_
3.5 Dental Implants & Abutments – Pipeline Products by Regulatory Path_x000D_
3.6 Dental Implants & Abutments – Pipeline Products by Estimated Approval Date_x000D_
4 Overview of Key Companies in United States, Dental Implants & Abutments Market_x000D_
4.1 Nobel Biocare Services AG_x000D_
4.1.1 Company Overview_x000D_
4.2 Straumann Holding AG_x000D_
4.2.1 Company Overview_x000D_
4.3 Dentsply Sirona Inc_x000D_
4.3.1 Company Overview_x000D_
4.4 ZimVie Inc_x000D_
4.4.1 Company Overview_x000D_
4.5 Osstem Implant Co Ltd_x000D_
4.5.1 Company Overview_x000D_
5 Recent Developments_x000D_
5.1 Corporate Communications_x000D_
5.1.1 Nov 06, 2025: Paho Promotes Interregional Cooperation to Strengthen Health Autonomy in Latin America and the Caribbean_x000D_
5.1.2 Nov 05, 2025: Center For Advanced Periodontal & Implant Therapy Launches Same-Day Full-Arch Dental Implant Solution_x000D_
5.1.3 Nov 01, 2025: Dale Medical Products, Inc. Introduces IV Line Manager_x000D_
5.1.4 Oct 31, 2025: University of Jordan Launches Research Group on Restorative Options for Dental Implants and Endodontically Treated Teeth_x000D_
5.1.5 Oct 02, 2025: Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer_x000D_
5.1.6 Sep 30, 2025: OUI Marks UCSF Silver Anniversary With Almost £3 Billion Raised By Spinouts_x000D_
5.1.7 Sep 25, 2025: TriAgenics Expands Funding Round_x000D_
5.1.8 Sep 10, 2025: Ormco Announces Spark Junior Clear Aligner Treatment For Younger Patients_x000D_
5.1.9 Aug 19, 2025: Zekjing Pharmaceuticals' Trispecific Antibody ZGGS34 Receives FDA Approval for Clinical Trial Application_x000D_
5.2 Financial Announcements_x000D_
5.2.1 Apr 21, 2026: Henry Schein to Webcast First Quarter 2026 Conference Call on Tuesday, May 5, 2026_x000D_
5.2.2 Apr 01, 2026: Stryker to Report First-Quarter Fiscal 2026 Results_x000D_
5.2.3 Nov 06, 2025: Hikma Pharmaceuticals announces the launch of STARJEMZA (ustekinumab-hmny) Injection, a biosimilar referencing STELARA (ustekinumab) Injection_x000D_
5.2.4 Oct 21, 2025: Henry Schein to Webcast Third Quarter 2025 Conference Call_x000D_
5.2.5 Jul 22, 2025: Henry Schein to Webcast Second Quarter 2025 Conference Call on Tuesday, August 5, 2025, at 8:00 a.m. ET_x000D_
5.3 Government and Public Interest_x000D_
5.3.1 Mar 20, 2026: NHS provides update on supply chain issues following cyber attack on Stryker_x000D_
5.3.2 Mar 04, 2026: Henry Schein to Participate in Upcoming Investor Conferences in March_x000D_
5.3.3 Nov 13, 2025: Henry Schein to Participate in Investor Conference in December_x000D_
5.3.4 Aug 26, 2025: Dentsply Sirona to Participate in Upcoming Investor Conferences_x000D_
5.3.5 Aug 22, 2025: Henry Schein to Participate in Upcoming Investor Conferences in September_x000D_
5.4 Other Significant Developments_x000D_
5.4.1 Nov 18, 2025: ClearChoice Dental Implant Center Introduces Insurance Assurance Program To Help Patients Reduce Implant Costs_x000D_
5.4.2 Nov 03, 2025: ClearChoice Launches Smile Mentor Program to Support New Patients_x000D_
5.4.3 Jul 29, 2025: Heartflow Receives Additional FDA 510(K) Clearance For HeartFlow FFRCT Analysis_x000D_
5.4.4 Jul 23, 2025: Zimvie Announces Exclusive Distribution Agreement With Osstem Implant To Expand Premium Dental Implant Offering in China_x000D_
5.5 Product News_x000D_
5.5.1 Mar 31, 2026: Glidewell Highlights Rising Digital Scanner Adoption as Open-Platform Dentistry Accelerates_x000D_
5.5.2 Dec 19, 2025: Glidewell Introduces Simply Natural 3D Flexible Partials_x000D_
5.5.3 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV_x000D_
5.5.4 Nov 26, 2025: Laser-Assisted Microbial Culturomics_x000D_
5.5.5 Nov 18, 2025: Neocis Unveils Yomi S, Next-Generation AI-Powered Dental Robot_x000D_
5.5.6 Nov 11, 2025: W&H Showcases Dental Innovations at Greater New York Dental Meeting_x000D_
5.5.7 Nov 05, 2025: Graphy Showcases Next-Generation Orthodontic Innovation at KAO 2025 and Global Partner Meeting in Seoul_x000D_
5.5.8 Oct 29, 2025: Align Technology Unveils Innovations for iTero Digital Solutions_x000D_
5.5.9 Oct 22, 2025: BrightCraft Dental Launches Sedation and Digital Full-Arch Transformation Model_x000D_
5.5.10 Aug 28, 2025: Dr. Robert G. Hale Introduces First FDA-Approved KLS Martin Preprosthetic Device for Patients Where Traditional Dental Implants Have Failed_x000D_
5.6 Strategy And Business Planning_x000D_
5.6.1 Nov 05, 2025: Bausch Health's OraPharma Expands into Canada and Puerto Rico to Address Periodontal Disease_x000D_
5.6.2 Sep 25, 2025: TriAgenics Expands Funding Round_x000D_
6 Appendix_x000D_
6.1 Research Methodology_x000D_
6.1.1 Coverage_x000D_
6.1.2 Secondary Research_x000D_
6.1.3 Primary Research_x000D_
6.1.4 Market Modeling and Forecasting_x000D_
6.1.5 Company Share Analysis_x000D_
6.1.6 Benchmarking_x000D_
6.2 GlobalData Consulting_x000D_
6.3 Contact Us_x000D_
6.4 Disclaimer